SurgiQuest, Inc. Launches AirSeal and AnchorPort Technologies in Japan Following NINSHO Certification
MILFORD, Conn., Sept. 25, 2012 /PRNewswire/ -- SurgiQuest, Inc. ("SurgiQuest", the "Company") today announced that the Company has received NINSHO Pre-Market Certification in Japan for both the AirSeal® Access System and AnchorPort® Trocar product line. Through its exclusive Japanese distributor, Century Medical, Inc., the Company gains access to the second largest laparoscopic and fastest growing robotic surgical market in the world with a direct, highly trained sales organization.
SurgiQuest's patented AirSeal System provides unprecedented access to the abdominal cavity during both laparoscopic and robotic minimally invasive surgery ("MIS"). Unlike conventional insufflation and standard trocar systems, the Company's breakthrough integrated platform ensures stable pneumoperitoneum, continuously and automatically evacuates smoke and plume when electrocautery, ultrasonic, or laser-based medical devices are used, and provides constant, valve-free trocar access to the abdominal cavity. The Company's distinctive AnchorPort Trocar features the world's only self-adjusting cannula which automatically adapts to the patient's abdominal wall thickness, facilitating precise hand instrument maneuverability in both multiple trocar and single incision laparoscopic ("SIL") surgery.
Leading robotic and laparoscopic surgeons worldwide are converting to the AirSeal System, touting reductions in operating time and other procedural efficiencies, improved anesthesia parameters and enhanced safety for the entire operating room staff. Ricardo Estape, MD, a world renowned Gynecologic Oncologist and the Director of Robotics for Florida's Baptist Health System, recently stated that "AirSeal does the job of an insufflator, smoke evacuator and pneumo-occluder all-in-one. As one of the biggest robotic programs in the country, we have seen its value and changed over all our systems to AirSeal."
"We are excited about both the NINSHO Certification and are delighted by the growth opportunity it represents for us and our distribution partner, CMI, as we launch in Japan," stated Mr. Kurt Azarbarzin, Founder and CEO of SurgiQuest. Mr. Akira Hoshino, President of Century Medical, Inc. states, "Many of our surgeons have been waiting patiently for this important regulatory clearance which will serve to accelerate the adoption of the AirSeal and AnchorPort platforms in our healthcare community, further improving clinical outcomes for Japanese patients while expanding associated economic benefits already experienced by other global healthcare communities."
SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technologies for robotic and laparoscopic surgery. Additional information about SurgiQuest products can be found at www.surgiquest.com.
CONTACT: Gary Tegan, PH: 203-799-2400
SOURCE SurgiQuest, Inc.